Long term use of oral diabetic drugs doubles the risk of fractures in women with type 2 diabetes. – Long term use of a popular class of oral diabetic drugs doubles the risk of fractures in women with type 2 diabetes, revealed by researchers at the Wake Forest University School of Medicine and the University of East Anglia.
Taking calcium and vitamin D supplements does not lower a woman?s risk of breast cancer, according to a randomized controlled trial. – Taking calcium and vitamin D supplements does not reduce breast cancer incidence in postmenopausal women, according to data from a randomized, doubled-blind, placebo-controlled trial published online November 11 in the Journal of the National Cancer Institute.
Vigorous activity protects against breast cancer, women 30% less likely to develop breast cancer. – Normal-weight women who carry out lots of vigorous exercise are approximately 30% less likely to develop breast cancer than those who don’t exercise vigorously.
An experimental Merck & Co. osteoporosis drug improved bone strength in postmenopausal women after two years of treatment with Odanacatib. – 2 year data from a Phase IIB study of odanacatib (formerly MK-0822), an investigational, selective cathepsin-K inhibitor in development for the treatment of osteoporosis by Merck & Co., Inc., demonstrated dose-dependent increases in bone mineral density (BMD) at the total hip, lumbar spine and femoral neck fracture sites and decreased indices of bone resorption compared to placebo in postmenopausal women with low BMD.
Women who survive five years after being diagnosed with breast cancer and after adjuvant systemic therapy have a good chance of remaining cancer free. – Breast cancer survivors continue to have a substantial risk of disease recurrence after five years of systemic therapy, according to a study published in the August 12 online issue of the Journal of the National Cancer Institute.
Difficulty falling asleep and staying asleep increases as women go through menopause, revealed by researchers. – Sleep difficulties, especially problems staying asleep, are relatively prevalent concerns among women going through the menopausal transition, revealed by researchers at Rush University Medical Center in Chicago.
Hormone replacement therapy (HRT) for peri- and postmenopausal symptoms increases disease recurrence in breast cancer survivors. – A new study HABITS revealed that breast cancer survivors who took hormone replacement therapy (HRT) for peri- and postmenopausal symptoms increases disease recurrence than those who did not take HRT.
Sedentary, overweight or obese women can improve their quality of life by exercising as little as 10 to 30 minutes a day, researchers reported. – Sedentary, overweight or obese women can improve their quality of life by exercising as little as 10 to 30 minutes a day, researchers reported at the American Heart Association’s Conference on Nutrition, Physical Activity and Metabolism.
Excess bodyweight, expressed as increased body-mass index (BMI), is associated with the risk of some common adult cancers. – Increased body mass index (BMI) increases the risk of common and less common cancers, and the level of risk can vary between the sexes and different ethnic groups depending on the type of cancer.
Fred Hutchinson Cancer Research Center leads first study designed to evaluate the association between combined HRT use and the risk of lobular breast cancers. – Postmenopausal women who take combined estrogen/progestin hormone-replacement therapy for three years or more face a fourfold increased risk of developing various forms of lobular breast cancer, according to new findings by researchers.
